ÂÜÀòÂÒÂ×

Vince Ippolito currently serves as President and Executive Chairman of Botanix Pharmaceuticals since May 2019, while also holding a board member position at Suneva Medical since August 2017. Previously, Vince Ippolito was President and Chief Operating Officer at Dermavant Sciences from September 2017 to January 2019, and prior to that, served as Chief Commercial Officer and Executive Vice President at Anacor Pharmaceuticals from March 2014 until its acquisition by Pfizer in June 2016. Vince Ippolito's experience also includes a role as Executive Vice President of Sales & Marketing at Medicis from January 2003 to March 2014, during which Medicis merged with Valeant in December 2012. Earlier in the career, Vince Ippolito worked at Novartis as Vice President for Respiratory, Dermatology, and Pediatric divisions from June 1986 to December 2002. Vince Ippolito holds a Bachelor of Arts in Business Administration from the University of Wisconsin-Eau Claire and a minor in East Asian Studies from Sophia University.